Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
|Articles|February 16, 2011
Your chance to be published in PTE!
Author(s)Stephanie Sutton
Want to take part in Pharm. Tech. Europe's roundtable on tabletting and stand a chance of seeing your opinion published in a magazine that reaches 18,000 professionals across Europe?
Advertisement
Want to take part in Pharm Tech Europe's feature on packaging and stand a chance at seeing your opinion published in a magazine that reaches 18,000 professionals across Europe?
We will be publishing a special feature on issues and innovations in packaging in the May print issue of Pharmaceutical Technology Europe and we would like to hear your opinions, grievances or wish lists!
Advertisement
Related to this article
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
Advertisement
Advertisement